MINERVAX ApS: Financial statements 2016
CVR: 32673287
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
MINERVAX ApS (CVR 32673287) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -20,024,576 and a net result of DKK -17,403,953 compared with DKK -13,102,889 the year before. Equity in the 2016 report amounted to DKK 11,508,664. The solvency ratio was 67.5%. The company had 3 employees in the financial year.
- Gross Profit
- DKK -20,024,576
- Profit/Loss
- DKK -17,403,953
- Equity
- DKK 11,508,664
- Total Assets
- DKK 17,049,986
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -20 mio. | -17.4 mio. | 11.5 mio. | 3 |
| 2015 | - | -15.6 mio. | -13.1 mio. | 413 t. | - |
| 2014 | - | -5.4 mio. | -4.4 mio. | 13.5 mio. | - |
| 2013 | 4.6 mio. | -2.6 mio. | -2.1 mio. | -719 t. | - |
| 2012 | - | -1.1 mio. | -846 t. | 1.4 mio. | - |
Official annual report
Find more companies like MINERVAX ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of September 27, 2016, Bent Østergaard has joined the board of directors of MINERVAX ApS.
As of September 27, 2016, Carl Fredrik Siwmark has left the board of directors of MINERVAX ApS.
MINERVAX ApS has published its annual report for 2015. Gross profit came to DKK -15,625,668, and the net result was DKK -13,102,889.
As of February 15, 2016, Emmanuelle Coutanceau has joined the board of directors of MINERVAX ApS.
As of February 15, 2016, Nanna Liebach Lüneborg has left the board of directors of MINERVAX ApS.
About MINERVAX ApS
MINERVAX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Veronica Gambillara Fonck (chair), Bita Sehat, Christopher J. Gagliardi and Emmanuelle Coutanceau. The company's owners include Novo Holdings A/S, SUNSTONE LIFE SCIENCE VENTURES FUND III K/S and Wellington Partners Life Sciences V GmbH & Co. KG. The company has 2 employees (2018). In 2025, the company reported a net result of EUR -31,530,000 compared with EUR -29,126,000 the year before. Equity in the 2025 report amounted to EUR 9,787,000.